Lista de obras -

A chromosome-centric human proteome project (C-HPP) to characterize the sets of proteins encoded in chromosome 17.

artículo científico publicado en 2012

AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor (EGFR), HER2, and HER3: preclinical activity in HER2 non-amplified inflammatory breast cancer models

artículo científico publicado en 2014

Aldehyde dehydrogenase1 immunohistochemical staining in primary breast cancer cells independently predicted overall survival but did not correlate with the presence of circulating or disseminated tumors cells

artículo científico publicado en 2014

Angiogenesis modulation in cancer research: novel clinical approaches

artículo científico publicado en 2002

Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer

scientific article published on 04 December 2019

Automated electrorotation to reveal dielectric variations related to HER-2/neu overexpression in MCF-7 sublines.

artículo científico publicado en 2002

CCR5 receptor antagonists block metastasis to bone of v-Src oncogene-transformed metastatic prostate cancer cell lines.

artículo científico publicado en 2014

CTC enumeration and characterization: moving toward personalized medicine

artículo científico publicado en 2014

CXCR4 expression in early breast cancer and risk of distant recurrence

artículo científico publicado en 2009

Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells

artículo científico publicado en 2010

Circulating giant macrophages as a potential biomarker of solid tumors

artículo científico publicado en 2014

Circulating tumor cells (CTCs) are associated with abnormalities in peripheral blood dendritic cells in patients with inflammatory breast cancer

artículo científico publicado en 2016

Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination

artículo científico publicado en 2014

Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment

artículo científico publicado en 2011

Circulating tumor cells in breast cancer: A tool whose time has come of age ⬇️

artículo científico publicado el 21 de abril de 2011

Circulating tumor cells in newly diagnosed inflammatory breast cancer

artículo científico publicado en 2015

Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer

artículo científico publicado en 2005

Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC

artículo científico publicado en 2022

Developmental therapeutics for inflammatory breast cancer: Biology and translational directions

artículo científico publicado en 2016

Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancer

artículo científico publicado en 2010

Differential radiosensitizing effect of valproic acid in differentiation versus self-renewal promoting culture conditions

artículo científico publicado en 2010

Dyadic coping in metastatic breast cancer

artículo científico publicado en 2010

Epidermal growth factor receptor tyrosine kinase inhibitor reverses mesenchymal to epithelial phenotype and inhibits metastasis in inflammatory breast cancer

artículo científico publicado en 2009

Expression of epithelial-mesenchymal transition-inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapy

artículo científico publicado en 2011

Factors predicting additional disease in the axilla in patients with positive sentinel lymph nodes after neoadjuvant chemotherapy

artículo científico publicado en 2008

Fingerprinting the circulating repertoire of antibodies from cancer patients

artículo científico publicado en 2002

GPR30 and estrogen receptor expression: new insights into hormone dependence of inflammatory breast cancer

artículo científico publicado en 2009

Genome wide proteomics of ERBB2 and EGFR and other oncogenic pathways in inflammatory breast cancer

artículo científico publicado en 2013

Inflammatory breast cancer (IBC): clues for targeted therapies

artículo científico publicado en 2013

Inflammatory breast cancer management in the national comprehensive cancer network: the disease, recurrence pattern, and outcome

artículo científico publicado en 2014

Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application

artículo científico publicado en 2016

Is Personalized Medicine Here?

artículo científico publicado en 2016

Locoregional treatment outcomes after multimodality management of inflammatory breast cancer

artículo científico publicado en 2008

Mesenchymal stem cells expressing GD2 and CD271 correlate with breast cancer-initiating cells in bone marrow.

artículo científico publicado en 2011

Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells

artículo científico publicado en 2010

Molecular characterization and targeted therapeutic approaches in breast cancer

artículo científico publicado en 2015

Molecular prognostic factors for breast cancer metastasis and survival

artículo científico publicado en 2002

Mutational studies on single circulating tumor cells isolated from the blood of inflammatory breast cancer patients

artículo científico publicado en 2017

Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer

artículo científico publicado en 2015

Phase I/II study of G3139 (Bcl-2 antisense oligonucleotide) in combination with doxorubicin and docetaxel in breast cancer.

artículo científico publicado en 2008

Primary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44⁺CD24lo cancer stem cell phenotype

artículo científico publicado en 2011

Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.

artículo científico publicado en 2005

Recurrent granulomatous mastitis mimicking inflammatory breast cancer ⬇️

artículo científico publicado el 25 de enero de 2011

Retrospective study of 18F-FDG PET/CT in the diagnosis of inflammatory breast cancer: preliminary data

artículo científico publicado en 2009

TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients

artículo científico publicado en 2014

Toxicity profile of approved anti-PD-1 monoclonal antibodies in solid tumors: a systematic review and meta-analysis of randomized clinical trials

artículo científico publicado en 2016

Trastuzumab in Primary Inflammatory Breast Cancer (IBC): High Pathological Response Rates and Improved Outcome

artículo científico publicado en 2010

Update on the management of inflammatory breast cancer

artículo científico publicado en 2003

Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline

artículo científico publicado en 2015

Lista de obras de

A chromosome-centric human proteome project (C-HPP) to characterize the sets of proteins encoded in chromosome 17.

AZD8931, an equipotent, reversible inhibitor of signaling by epidermal growth factor receptor (EGFR), HER2, and HER3: preclinical activity in HER2 non-amplified inflammatory breast cancer models

Aldehyde dehydrogenase1 immunohistochemical staining in primary breast cancer cells independently predicted overall survival but did not correlate with the presence of circulating or disseminated tumors cells

Angiogenesis modulation in cancer research: novel clinical approaches

Association of a novel circulating tumor DNA next-generating sequencing platform with circulating tumor cells (CTCs) and CTC clusters in metastatic breast cancer

Automated electrorotation to reveal dielectric variations related to HER-2/neu overexpression in MCF-7 sublines.

CCR5 receptor antagonists block metastasis to bone of v-Src oncogene-transformed metastatic prostate cancer cell lines.

CTC enumeration and characterization: moving toward personalized medicine

CXCR4 expression in early breast cancer and risk of distant recurrence

Characterizing cancer cells with cancer stem cell-like features in 293T human embryonic kidney cells

Circulating giant macrophages as a potential biomarker of solid tumors

Circulating tumor cells (CTCs) are associated with abnormalities in peripheral blood dendritic cells in patients with inflammatory breast cancer

Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination

Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment

Circulating tumor cells in breast cancer: A tool whose time has come of age ⬇️

Circulating tumor cells in newly diagnosed inflammatory breast cancer

Circulating tumor cells: a novel prognostic factor for newly diagnosed metastatic breast cancer

Comparative transcriptional analyses of preclinical models and patient samples reveal MYC and RELA driven expression patterns that define the molecular landscape of IBC

Developmental therapeutics for inflammatory breast cancer: Biology and translational directions

Different gene expressions are associated with the different molecular subtypes of inflammatory breast cancer

Differential radiosensitizing effect of valproic acid in differentiation versus self-renewal promoting culture conditions

Dyadic coping in metastatic breast cancer

Epidermal growth factor receptor tyrosine kinase inhibitor reverses mesenchymal to epithelial phenotype and inhibits metastasis in inflammatory breast cancer

Expression of epithelial-mesenchymal transition-inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapy

Factors predicting additional disease in the axilla in patients with positive sentinel lymph nodes after neoadjuvant chemotherapy

Fingerprinting the circulating repertoire of antibodies from cancer patients

GPR30 and estrogen receptor expression: new insights into hormone dependence of inflammatory breast cancer

Genome wide proteomics of ERBB2 and EGFR and other oncogenic pathways in inflammatory breast cancer

Inflammatory breast cancer (IBC): clues for targeted therapies

Inflammatory breast cancer management in the national comprehensive cancer network: the disease, recurrence pattern, and outcome

Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application

Is Personalized Medicine Here?

Locoregional treatment outcomes after multimodality management of inflammatory breast cancer

Mesenchymal stem cells expressing GD2 and CD271 correlate with breast cancer-initiating cells in bone marrow.

Mesenchymal stem cells promote mammosphere formation and decrease E-cadherin in normal and malignant breast cells

Molecular characterization and targeted therapeutic approaches in breast cancer

Molecular prognostic factors for breast cancer metastasis and survival

Mutational studies on single circulating tumor cells isolated from the blood of inflammatory breast cancer patients

Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer

Phase I/II study of G3139 (Bcl-2 antisense oligonucleotide) in combination with doxorubicin and docetaxel in breast cancer.

Primary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44⁺CD24lo cancer stem cell phenotype

Prognostic role of a multigene reverse transcriptase-PCR assay in patients with node-negative breast cancer not receiving adjuvant systemic therapy.

Recurrent granulomatous mastitis mimicking inflammatory breast cancer ⬇️

Retrospective study of 18F-FDG PET/CT in the diagnosis of inflammatory breast cancer: preliminary data

TP53 mutations detected in circulating tumor cells present in the blood of metastatic triple negative breast cancer patients

Toxicity profile of approved anti-PD-1 monoclonal antibodies in solid tumors: a systematic review and meta-analysis of randomized clinical trials

Trastuzumab in Primary Inflammatory Breast Cancer (IBC): High Pathological Response Rates and Improved Outcome

Update on the management of inflammatory breast cancer

Use of Biomarkers to Guide Decisions on Systemic Therapy for Women With Metastatic Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline